Cargando…
SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
BACKGROUND: Sulfatase 2 (SULF2) is a member of the sulfatase family, and its expression and clinical significance in bladder cancer (BCa) are not currently known. In this study, we attempted to evaluate SULF2 expression in BCa patients who underwent radical cystectomy (RC) and the relationship betwe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506778/ https://www.ncbi.nlm.nih.gov/pubmed/34733991 http://dx.doi.org/10.21037/atm-21-4102 |
_version_ | 1784581759198822400 |
---|---|
author | Huang, Jianhua Li, Cheng Zhang, Wentao Yang, Fuhan Wang, Ruiliang Zhang, Junfeng Li, Wei Yao, Xudong |
author_facet | Huang, Jianhua Li, Cheng Zhang, Wentao Yang, Fuhan Wang, Ruiliang Zhang, Junfeng Li, Wei Yao, Xudong |
author_sort | Huang, Jianhua |
collection | PubMed |
description | BACKGROUND: Sulfatase 2 (SULF2) is a member of the sulfatase family, and its expression and clinical significance in bladder cancer (BCa) are not currently known. In this study, we attempted to evaluate SULF2 expression in BCa patients who underwent radical cystectomy (RC) and the relationship between SULF2 expression and clinical-pathological characteristics. METHODS: Data on SULF2 expression in BCa tissues was obtained from the Oncomine database and the Gene Expression Omnibus (GEO). The expression of SULF2 and vascular endothelial growth factor-D (VEGF-D) in BCa was evaluated by immunohistochemistry (IHC) in tissues from 203 patients who had undergone RC. We also explored the value of the measurement of SULF2 and VEGF-D expression for diagnosis and prognosis in BCa patients with lymphatic metastasis. RESULTS: We found an increase in SULF2 messenger RNA (mRNA) levels and gene amplification in BCa tissues from the Oncomine database. High expression of SULF2 was detected in 91/203 (44.8%) of BCa patients. Among these patients, 27 of 42 (64.3%) with lymphatic metastasis showed high SULF2 expression. Univariate analysis showed that tumor size, pathological stage, lymphatic metastasis, vascular infiltration, perineural infiltration, hydronephrosis, and VEGF-D and SULF2 expression were related to prognosis in BCa patients, and multivariable Cox regression analysis showed that SULF2 expression was an independent prognostic indicator. Receiver operating characteristic (ROC) analysis revealed that SULF2 expression resulted in an increased area under the curve (AUC) of 0.707, with a sensitivity of 71.4% and a specificity of 61.5%. CONCLUSIONS: The upregulation of SULF2 is associated with poor prognosis in high-grade BCa patients. It might be a novel diagnostic marker for BCa patients with lymphatic metastasis. |
format | Online Article Text |
id | pubmed-8506778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-85067782021-11-02 SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis Huang, Jianhua Li, Cheng Zhang, Wentao Yang, Fuhan Wang, Ruiliang Zhang, Junfeng Li, Wei Yao, Xudong Ann Transl Med Original Article BACKGROUND: Sulfatase 2 (SULF2) is a member of the sulfatase family, and its expression and clinical significance in bladder cancer (BCa) are not currently known. In this study, we attempted to evaluate SULF2 expression in BCa patients who underwent radical cystectomy (RC) and the relationship between SULF2 expression and clinical-pathological characteristics. METHODS: Data on SULF2 expression in BCa tissues was obtained from the Oncomine database and the Gene Expression Omnibus (GEO). The expression of SULF2 and vascular endothelial growth factor-D (VEGF-D) in BCa was evaluated by immunohistochemistry (IHC) in tissues from 203 patients who had undergone RC. We also explored the value of the measurement of SULF2 and VEGF-D expression for diagnosis and prognosis in BCa patients with lymphatic metastasis. RESULTS: We found an increase in SULF2 messenger RNA (mRNA) levels and gene amplification in BCa tissues from the Oncomine database. High expression of SULF2 was detected in 91/203 (44.8%) of BCa patients. Among these patients, 27 of 42 (64.3%) with lymphatic metastasis showed high SULF2 expression. Univariate analysis showed that tumor size, pathological stage, lymphatic metastasis, vascular infiltration, perineural infiltration, hydronephrosis, and VEGF-D and SULF2 expression were related to prognosis in BCa patients, and multivariable Cox regression analysis showed that SULF2 expression was an independent prognostic indicator. Receiver operating characteristic (ROC) analysis revealed that SULF2 expression resulted in an increased area under the curve (AUC) of 0.707, with a sensitivity of 71.4% and a specificity of 61.5%. CONCLUSIONS: The upregulation of SULF2 is associated with poor prognosis in high-grade BCa patients. It might be a novel diagnostic marker for BCa patients with lymphatic metastasis. AME Publishing Company 2021-09 /pmc/articles/PMC8506778/ /pubmed/34733991 http://dx.doi.org/10.21037/atm-21-4102 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Huang, Jianhua Li, Cheng Zhang, Wentao Yang, Fuhan Wang, Ruiliang Zhang, Junfeng Li, Wei Yao, Xudong SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title | SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title_full | SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title_fullStr | SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title_full_unstemmed | SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title_short | SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
title_sort | sulf2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506778/ https://www.ncbi.nlm.nih.gov/pubmed/34733991 http://dx.doi.org/10.21037/atm-21-4102 |
work_keys_str_mv | AT huangjianhua sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT licheng sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT zhangwentao sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT yangfuhan sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT wangruiliang sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT zhangjunfeng sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT liwei sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis AT yaoxudong sulf2isanoveldiagnosticandprognosticmarkerforhighgradebladdercancerwithlymphaticmetastasis |